SCHEMBL7258124

SCHEMBL7258124

COC(=O)c1ccc(CNc2nc(Cl)nc3cccc(Cl)c23)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.50
TBXA2R P21731 4/20 0.50
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
PDE5A O76074 1/20 0.45
APP P05067 1/20 0.45
CTNNB1 P35222 2/20 0.45
TCF7L2 Q9NQB0 2/20 0.45
ALDH1A1 P00352 1/20 0.44
CNR1 P21554 1/20 0.44
YTHDC1 Q96MU7 1/20 0.43
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
LOXL2 Q9Y4K0 1/20 0.42
ESR1 P03372 2/20 0.41
JAK2 O60674 1/20 0.41
IGF1R P08069 1/20 0.41
PIM1 P11309 1/20 0.41
SRC P12931 1/20 0.41
CSNK2A2 P19784 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1502579 0.86 KCNA5 (0.57) DRD2TBXA2RCA1CA2PDE5A
SCHEMBL3110419 0.83 CCNE1 (0.52) PDE5AAPPTP53ESR1JAK2
SCHEMBL3641178 0.80 APP (0.68) PDE5AAPPALDH1A1MAPTESR1
SCHEMBL3639802 0.79 APP (0.52) PDE5AAPPCTNNB1TCF7L2MAPT
SCHEMBL7070989 0.77 PDE4A (0.48) DRD2TBXA2RCA1CA2ALDH1A1
SCHEMBL7254637 0.77 CNR1 (0.58) DRD2TBXA2RPDE5AAPPCTNNB1
SCHEMBL7254554 0.77 CNR1 (0.56) DRD2TBXA2RCA1CA2PDE5A
SCHEMBL12170196 0.77 KCNA5 (0.73) JAK2IGF1RPIM1SRCCSNK2A2
SCHEMBL1063561 0.76 CA1 (0.56) DRD2TBXA2RCA1CA2ALDH1A1
SCHEMBL7068349 0.74 CA1 (0.48) DRD2TBXA2RCA1CA2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003055866-A1 QUINAZOLINE AND QUINOLINE DERIVATIVE COMPOUNDS AS INHIBITORS OF PROLYLPEPTIDASE, INDUCERS OF APOPTOSIS AND CANCER TREATMENT AGENTS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-10 WO disclosed